NCT05511415View on ClinicalTrials.gov

In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

November 21, 2024

Study Completion Date

November 22, 2024

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

Oxytocin solution, 20nM concentration

DRUG

Dexmedetomidine

Dexmedetomidine (10-9M to 10-4M)

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER